Development and in vivo evaluation of 18F-labeled PET tracers covalently targeting KRAS-G12C for noninvasive cancer diagnosis and therapy monitoring.
Saved in:
| Title: | Development and in vivo evaluation of 18F-labeled PET tracers covalently targeting KRAS-G12C for noninvasive cancer diagnosis and therapy monitoring. |
|---|---|
| Authors: | Willmann M; Department of Nuclear Medicine, Hannover Medical School, Germany., Bankstahl JP; Department of Nuclear Medicine, Hannover Medical School, Germany., Bengel FM; Department of Nuclear Medicine, Hannover Medical School, Germany., Drechsler C; Merck Healthcare KGaA, Darmstadt, Germany., Esdar C; Merck Healthcare KGaA, Darmstadt, Germany., Gläser K; Merck Healthcare KGaA, Darmstadt, Germany., Lopez AU; Merck Healthcare KGaA, Darmstadt, Germany., Ross T; Merck Healthcare KGaA, Darmstadt, Germany., Schieferstein H; Merck Healthcare KGaA, Darmstadt, Germany., Ross TL; Department of Nuclear Medicine, Hannover Medical School, Germany. |
| Source: | Theranostics [Theranostics] 2026 May 01; Vol. 16 (12), pp. 6485-6496. Date of Electronic Publication: 2026 May 01 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1838-7640 |
|---|---|
| DOI: | 10.7150/thno.123741 |
